Join the Fight Againt Cancer

03 February 2009

Tags: kay yow


Breast cancer now occurs in one in eight women, and Nike is calling on you to help in the fight.

Nike has joined forces with the Kay Yow/WBCA Cancer Fund to bring awareness to the fight against cancer. Some of college basketball’s leading teams, coaches and officials have partnered to raise awareness and funds to fight breast cancer.

During the month of February, over 1000 women's and 300 men's basketball programs and over 4000 officials will participate in this great cause. Fifteen women’s teams including North Carolina State, Rutgers, Georgia, LSU will be sporting special pink uniforms as well as special edition pink Hyperdunks and Nike Blue Chip Lows to raise awareness of the campaign.

Starting February 5th, you can show your support with the limited edition Kay Yow collection. Nike will donate a minimum of $2 from every purchase to the Kay Yow/WBCA Cancer Fund.

The Collection:

http://inside.nike.com/servlet/JiveServlet/downloadImage/38-9875-20615/kayyow_hyperdunk.jpg

http://inside.nike.com/servlet/JiveServlet/downloadImage/38-9875-20616/kayyow_bluechip.jpg

http://inside.nike.com/servlet/JiveServlet/downloadImage/38-9875-20619/kayyow_shirt.jpg

http://inside.nike.com/servlet/JiveServlet/downloadImage/38-9875-20618/kayyow_ball.jpg

The tournament:
Also, tune in to these nationally televised games that will feature your favorite teams in the Kay Yow collection:

Sunday, February 15
Illinois vs. Purdue @ 12:00 PM ET
Georgia vs. Vanderbilt @ 12:00 PM ET
Marist vs. Hartford @ 12:45 PM ET
Rutgers vs. Maryland @ 1PM ET
Texas vs. Iowa State @ 2:30 PM ET
Pittsburgh vs. Connecticut @ 3:30 PM ET
Virginia vs. North Carolina State @ 3:30 PM ET
Southern Miss at Marshall @ 3:30 PM ET
Memphis at Tulsa @ 3:00 PM ET

Monday, February 16
Duke vs. Tennessee @ 7:30PM ET

In addition, during All-star weekend several WNBA players will be showing their love by wearing special edition Kay Yow products.

To find out how you can make a difference visit www.jimmyv.org.

Comments (0)

No comments have been made.